HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

(+-)-Tetrahydroberberine

HCID 34458
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
29074-38-2
Standard SMILES
COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1C2)OCO4
InChIKey
VZTUIEROBZXUFA-UHFFFAOYSA-N
Molecular formula
C20H21NO4
Average molar mass
339.4 g/mol
Monoisotopic mass
339.14705815

Overview

Canadine is a berberine alkaloid that is 5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline substituted by methoxy groups at positions 9 and 10. It is a berberine alkaloid, an aromatic ether, an oxacycle and an organic heteropentacyclic compound.

Names & identifiers

Preferred name
(+-)-Tetrahydroberberine
IUPAC
16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene
English name
TETRAHYDROBERBERINE
Molecular formula
C20H21NO4
Molecular weight
339.39

Names & synonyms

Canadine522-97-4XanthopuccineCanadindl-TetrahydroberberineDTXSID5022724V2SSH085X89,10-Dimethoxy-2,3-(methylenedioxy)berbineNSC-36351NSC-94918DTXCID80272416,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene
Show more names
THBNsc36351(+-)-hoxyAKOS 213-56(+-)-canadinCanadine (DL-)10-dimethoxy-2,3-(methylenedioxy)-(+-)-berbinbenzo(g)-1,3-benzodioxolo(5,6-a)quinolizine,5,8,13,13a-tetrahydro-9,10-dimet
CHEBI:229985,8,13,13a-tetrahydro-9,10-dimethoxy-6H-benzo(g)-1,3-benzodioxolo(5,6-a)quinolizine(+-)-Tetrahydroberberine16,17-dimethoxy-5,7-dioxa-13-azapentacyclo(11.8.0.02,10.04,8.015,20)henicosa-2,4(8),9,15(20),16,18-hexaeneRefChem:573702208-338-2Tetrahydroberberinedl-Canadine

Database identifiers

CAS
29074-38-2、5096-57-1、522-97-4

Properties

Computed structural properties

XLogP
3.1
Topological polar surface area
40.2 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
5
Rotatable bonds
2
Heavy atoms
25
Formal charge
0
Complexity
488

Experimental & physicochemical properties

Solubility2.1 [ug/mL] (The mean of the results at pH 7.4)

Physicochemical properties

Melting point
172 ° · 172° (Spth, Julian), also reported as 163-165° (Cushman, Dekon)
storage temp.
2 · 2-8°C
solubility
10 mg/mL, · DMSO: >10 mg/mL, soluble
form
solid
color
yellow
FDA UNII
2 SSH085X8 · V2SSH085X8
Hazard Codes
Xn
Risk Statements
22 · 22
Safety Statements
36 · 36
WGK Germany
3 · 3

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 2.4% (1 of 41) of reports.

Warning

H302 (97.6%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 2 notifications to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (97.6%)

Safety data

wgk
3
risk_code
22
hazard_code
Xn
safety_code
36

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 3 items

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

Suppliers100 total

成都普瑞法科技开发有限公司+86-028-82633397 18982077548 · [email protected]
南通飞宇生物科技有限公司0513-68819626 15152877458 · [email protected]
成都曼思特生物科技有限公司18010516991 · [email protected]
南京普怡生物科技有限公司13814510036 · [email protected]
合肥翰刚医药科技有限公司+8618062405514 · [email protected]
成都市久鼎化学技术有限公司18584079237 · [email protected]
云南西力生物技术股份有限公司0871-65217109 · [email protected]
上海如吉生物科技发展有限公司+86-21-65211385-8001 36031160 · [email protected]

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
34458
DTXSID
DTXSID5022724
ChEMBL
CHEMBL275097、CHEMBL490533
ChEBI
CHEBI:22998
UNII
V2SSH085X8
EC Number
208-338-2、225-815-0
Nikkaji
J252.482A
Dayang Chem (Hangzhou) Co.,Ltd.
+86-0571-88938639 17705817739 · [email protected]
上海晶抗生物工程有限公司021-54721350 13524668266 · [email protected]
大连美仑生物技术有限公司0411-62910999 13889544652 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
梯希爱(上海)化工贸易有限公司021-61109150 · [email protected]
上海诗丹德标准技术服务有限公司021-021-57127007-6622-6622 17621252073 · [email protected]
天津万象恒远科技有限公司15722085254 · [email protected]
成都普思生物科技股份有限公司028-85370565-229 18080489829 · [email protected]
InvivoChem中国13549236410 · [email protected]
成都普菲德生物技术有限公司028-82610909 13388174823 · [email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]
上海融禾医药科技发展有限公司17301719108 13341702378 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
武汉丰泰威远科技有限公司+86-27-8746-5837 +86-18627785180 · [email protected]
武汉丰泰威远科技有限公司027-87465837 19945049750 · [email protected]
佛山宝诺生物科技有限公司0757-85921206 18520245316 · [email protected]
贵州迪大科技有限责任公司0851-8475-2296 18096062265 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
成都锦然生物科技有限公司028-83311324 1278112614 · [email protected]
成都瑞芬思德丹生物科技有限公司2355253622; 18981954830 · [email protected]
上海倍卓生物科技有限公司021-61119791,13386096464 · [email protected]
上海将来实业股份有限公司400-0066400 13621662912 · [email protected]
成都迈斯克医药科技有限公司028-84552636 18084815636 · [email protected]
四川省维克奇生物科技有限公司028-81700200 18116577057 · [email protected]
雷丁试剂0510-85629785 18013409632 · [email protected]
上海卓因生物科技有限公司021-61317773 · [email protected]
成都仪睿生物科技有限公司18224028459 18224028459 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海永叶生物科技有限公司86-021-61559134 15921386130 · [email protected]
陕西缔都医药化工有限公司029-81024372 17792795018 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
上海鼎问化学科技有限公司+86-21-31664694 157 21077413 · [email protected]
成都钠钶锂生物科技有限公司028-61983833 19138982515 · [email protected]
TargetMol中国(陶术生物)021-021-33632979 15002134094 · [email protected]
上海语纯生物科技有限公司021-021-52273538 17321241593 · [email protected]
武汉天植生物技术有限公司18607101326 15172504745 · [email protected]
上海昕凯医药科技有限公司21-619849051-1 18521059765 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
上海皓之翔生物科技有限公司(原上海拓青化工有限公司)526763801 13301653310 · [email protected]
上海萄普生物医药技术有限公司15900573766 18018507602 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
Wuhan ChemNorm Biotech Co.,Ltd.+86-27-8439 4403 18971486879 · [email protected]
Additional notes · 1 item

DefinitionChEBI: Canadine is a berberine alkaloid that is 5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline substituted by methoxy groups at positions 9 and 10. It is a berberine alkaloid, an organic heteropentacyclic compound, an aromatic ether and an oxacycle.